ID   AAAT_HUMAN              Reviewed;         541 AA.
AC   Q15758;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2002, sequence version 2.
DT   01-OCT-2014, entry version 142.
DE   RecName: Full=Neutral amino acid transporter B(0);
DE            Short=ATB(0);
DE   AltName: Full=Baboon M7 virus receptor;
DE   AltName: Full=RD114/simian type D retrovirus receptor;
DE   AltName: Full=Sodium-dependent neutral amino acid transporter type 2;
DE   AltName: Full=Solute carrier family 1 member 5;
GN   Name=SLC1A5; Synonyms=ASCT2, M7V1, RDR, RDRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Choriocarcinoma;
RX   PubMed=8702519; DOI=10.1074/jbc.271.31.18657;
RA   Kekuda R., Prasad P.D., Fei Y.-J., Torres-Zamorano V., Sinha S.,
RA   Yang-Feng T.L., Leibach F.H., Ganapathy V.;
RT   "Cloning of the sodium-dependent, broad-scope, neutral amino acid
RT   transporter Bo from a human placental choriocarcinoma cell line.";
RL   J. Biol. Chem. 271:18657-18661(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION AS A VIRAL
RP   RECEPTOR.
RX   PubMed=10051606; DOI=10.1073/pnas.96.5.2129;
RA   Rasko J.E.J., Battini J.L., Gottschalk R.J., Mazo I., Miller A.D.;
RT   "The RD114/simian type D retrovirus receptor is a neutral amino acid
RT   transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2129-2134(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION AS A VIRAL
RP   RECEPTOR.
RX   PubMed=10196349;
RA   Tailor C.S., Nouri A., Zhao Y., Takeuchi Y., Kabat D.;
RT   "A sodium-dependent neutral-amino-acid transporter mediates infections
RT   of feline and baboon endogenous retroviruses and simian type D
RT   retroviruses.";
RL   J. Virol. 73:4470-4474(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ouyang D.-Y., Xu L.-H., He X.-H., Zha Q.-B., Guo H., Gao Q.,
RA   Zhang Y.-T.;
RT   "Cloning of ASCT2 cDNA from MCF-7 cells and its expression in B16
RT   cells.";
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT LEU-512.
RC   TISSUE=Esophagus, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-541 (ISOFORM 1), AND ALTERNATIVE
RP   INITIATION.
RX   PubMed=11350958; DOI=10.1074/jbc.M100737200;
RA   Tailor C.S., Marin M., Nouri A., Kavanaugh M.P., Kabat D.;
RT   "Truncated forms of the dual function human ASCT2 neutral amino acid
RT   transporter/retroviral receptor are translationally initiated at
RT   multiple alternative CUG and GUG codons.";
RL   J. Biol. Chem. 276:27221-27230(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=10708449; DOI=10.1128/JVI.74.7.3321-3329.2000;
RA   Blond J.-L., Lavillette D., Cheynet V., Bouton O., Oriol G.,
RA   Chapel-Fernandes S., Mandrand B., Mallet F., Cosset F.-L.;
RT   "An envelope glycoprotein of the human endogenous retrovirus HERV-W is
RT   expressed in the human placenta and fuses cells expressing the type D
RT   mammalian retrovirus receptor.";
RL   J. Virol. 74:3321-3329(2000).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-535, VARIANT
RP   [LARGE SCALE ANALYSIS] LEU-512, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   FUNCTION, INTERACTION WITH ERVH48-1, AND SUBCELLULAR LOCATION.
RX   PubMed=23492904; DOI=10.1038/srep01462;
RA   Sugimoto J., Sugimoto M., Bernstein H., Jinno Y., Schust D.;
RT   "A novel human endogenous retroviral protein inhibits cell-cell
RT   fusion.";
RL   Sci. Rep. 3:1462-1462(2013).
CC   -!- FUNCTION: TEST-function-1: Sodium-dependent amino acids
CC       transporter that has a broad substrate specificity, with a
CC       preference for zwitterionic amino acids. It accepts as substrates
CC       all neutral amino acids, including glutamine, asparagine, and
CC       branched-chain and aromatic amino acids, and excludes methylated,
CC       anionic, and cationic amino acids. May also be activated by
CC       insulin. Through binding of the fusogenic protein syncytin-1/ERVW-
CC       1 may mediate trophoblasts syncytialization, the spontaneous
CC       fusion of their plasma membranes, an essential process in
CC       placental development (PubMed:10708449, PubMed:23492904).
CC       {ECO:0000269|PubMed:10051606, ECO:0000269|PubMed:10196349}. TEST-
CC       function-2: Acts as a cell surface receptor for feline endogenous
CC       virus RD114, baboon M7 endogenous virus and type D simian
CC       retroviruses (PubMed:10051606, PubMed:10196349).
CC       {ECO:0000269|PubMed:10708449, ECO:0000269|PubMed:23492904}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Absorption:
CC         Abs(max)=465 nm {ECO:0000255};
CC         Note=TEST-bpc-absorption-note-1: The above maximum is for the
CC         oxidized form. {ECO:0000255}; TEST-bpc-absorption-note-2: Shows
CC         a maximal peak at 330 nm in the reduced form.
CC         {ECO:0000269|PubMed:10051606}; TEST-bpc-absorption-note-3: These
CC         absorption peaks are for the tryptophylquinone cofactor.
CC         {ECO:0000269|PubMed:10196349};
CC       Kinetic parameters:
CC         KM=5.4 uM for tyramine {ECO:0000255};
CC         Vmax=17 umol/min/mg enzyme {ECO:0000255};
CC         Note=TEST-bpc-kinetics-note-1: The enzyme is substrate inhibited
CC         at high substrate concentrations (Ki=1.08 mM for tyramine).
CC         {ECO:0000255}; TEST-bpc-kinetics-note-2: Bla bla bla.
CC         {ECO:0000269|PubMed:10051606};
CC       pH dependence:
CC         TEST-bpc-phDependence-1: Optimum pH is 6.5. {ECO:0000255};
CC         TEST-bpc-phDependence-2: Works also at pH 7.
CC         {ECO:0000269|PubMed:10051606};
CC       Temperature dependence:
CC         TEST-bpc-temperatureDependence-1: Optimum temperature is above
CC         30 degrees Celsius. {ECO:0000255};
CC         TEST-bpc-temperatureDependence-2: Heating to 60 degrees Celsius
CC         for 1 minute abolishes 72% of the original mutase activity, and
CC         no activity remains after 8 minutes.
CC         {ECO:0000269|PubMed:10051606};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10196349};
CC       Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:10196349}. Note=TEST-
CC       subcell-note-1: In microneme complexes. {ECO:0000255}. TEST-
CC       subcell-note-2: In rhoptry complexes.
CC       {ECO:0000269|PubMed:10051606}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=TEST-altprod-comment-1: A number of isoforms are
CC         produced by alternative initiation.
CC         {ECO:0000269|PubMed:11350958}; TEST-altprod-comment-2: Isoforms
CC         start at multiple alternative CUG and GUG codons.
CC         {ECO:0000269|PubMed:14702039};
CC       Name=1;
CC         IsoId=Q15758-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15758-2; Sequence=VSP_046354;
CC         Note=TEST-altprod-note-1: Derived from EST data.
CC         {ECO:0000269|PubMed:11350958}; TEST-altprod-note-2: No
CC         experimental confirmation available.
CC         {ECO:0000269|PubMed:14702039};
CC       Name=3;
CC         IsoId=Q15758-3; Sequence=VSP_046851;
CC         Note=No experimental confirmation available.;
CC   -!- RNA EDITING: Modified_positions=381 {ECO:0000269|PubMed:10708449,
CC       ECO:0000269|PubMed:11350958}, 398 {ECO:0000269|PubMed:10708449,
CC       ECO:0000269|PubMed:11350958}; Note=TEST-rna-editing-note-1:
CC       Partially edited. {ECO:0000255}; TEST-rna-editing-note-2: Target
CC       of Adar. {ECO:0000269|PubMed:10051606};
CC   -!- DISEASE: Mental retardation, X-linked, associated with fragile
CC       site FRAXE (MRFRAXE) [MIM:309548]: A form of mild to moderate
CC       mental retardation associated with learning difficulties,
CC       communication deficits, attention problems, hyperactivity, and
CC       autistic behavior. It is associated with a fragile site on
CC       chromosome Xq28. Mental retardation is characterized by
CC       significantly below average general intellectual functioning
CC       associated with impairments in adaptive behavior and manifested
CC       during the developmental period. {ECO:0000255}. Note=TEST-disease-
CC       note-1: The disease is caused by mutations affecting the gene
CC       represented in this entry. It is caused either by silencing of the
CC       AFF2 gene as a consequence of a CCG expansion located upstream of
CC       this gene or by deletion within the gene. {ECO:0000255}. TEST-
CC       disease-note-2: Loss of AFF2 expression is correlated with FRAXE
CC       CCG(N) expansion. Normal individuals have 6-35 copies of the
CC       repeat, whereas cytogenetically positive, developmentally delayed
CC       males have more than 200 copies and show methylation of the
CC       associated CPG island. {ECO:0000269|PubMed:10051606}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U53347; AAC50629.1; -; mRNA.
DR   EMBL; AF102826; AAD09812.1; -; mRNA.
DR   EMBL; AF105423; AAD27806.1; -; mRNA.
DR   EMBL; GQ919058; ACX53626.1; -; mRNA.
DR   EMBL; AK292690; BAF85379.1; -; mRNA.
DR   EMBL; AK299137; BAG61189.1; -; mRNA.
DR   EMBL; AK301661; BAG63136.1; -; mRNA.
DR   EMBL; AK316546; BAH14917.1; -; mRNA.
DR   EMBL; AC008622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW57446.1; -; Genomic_DNA.
DR   EMBL; BC000062; AAH00062.1; -; mRNA.
DR   EMBL; AF334818; AAK77026.1; -; mRNA.
DR   CCDS; CCDS12692.1; -.
DR   CCDS; CCDS46125.1; -.
DR   CCDS; CCDS46126.1; -.
DR   RefSeq; NP_001138616.1; NM_001145144.1.
DR   RefSeq; NP_001138617.1; NM_001145145.1.
DR   RefSeq; NP_005619.1; NM_005628.2.
DR   UniGene; Hs.631582; -.
DR   ProteinModelPortal; Q15758; -.
DR   SMR; Q15758; 59-482.
DR   BioGrid; 112401; 16.
DR   IntAct; Q15758; 6.
DR   MINT; MINT-5001314; -.
DR   STRING; 9606.ENSP00000303623; -.
DR   DrugBank; DB00174; L-Asparagine.
DR   DrugBank; DB00130; L-Glutamine.
DR   GuidetoPHARMACOLOGY; 874; -.
DR   TCDB; 2.A.23.3.3; the dicarboxylate/amino acid:cation (na(+) or h(+)) symporter (daacs) family.
DR   DMDM; 21542389; -.
DR   MaxQB; Q15758; -.
DR   PaxDb; Q15758; -.
DR   PeptideAtlas; Q15758; -.
DR   PRIDE; Q15758; -.
DR   DNASU; 6510; -.
DR   Ensembl; ENST00000412532; ENSP00000397924; ENSG00000105281.
DR   Ensembl; ENST00000434726; ENSP00000406532; ENSG00000105281.
DR   Ensembl; ENST00000542575; ENSP00000444408; ENSG00000105281.
DR   GeneID; 6510; -.
DR   KEGG; hsa:6510; -.
DR   UCSC; uc002pfr.3; human.
DR   CTD; 6510; -.
DR   GeneCards; GC19M047278; -.
DR   H-InvDB; HIX0015262; -.
DR   HGNC; HGNC:10943; SLC1A5.
DR   HPA; HPA035239; -.
DR   HPA; HPA035240; -.
DR   MIM; 109190; gene.
DR   neXtProt; NX_Q15758; -.
DR   PharmGKB; PA35830; -.
DR   eggNOG; COG1301; -.
DR   HOVERGEN; HBG000080; -.
DR   InParanoid; Q15758; -.
DR   KO; K05616; -.
DR   OMA; LVRNIFP; -.
DR   OrthoDB; EOG7RV9G2; -.
DR   PhylomeDB; Q15758; -.
DR   TreeFam; TF315206; -.
DR   Reactome; REACT_13796; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC1A5; human.
DR   GeneWiki; SLC1A5; -.
DR   GenomeRNAi; 6510; -.
DR   PRO; PR:Q15758; -.
DR   Bgee; Q15758; -.
DR   CleanEx; HS_SLC1A5; -.
DR   GO; GO:0070062; C:extracellular vesicular exosome; .
DR   GO; GO:0005794; C:Golgi apparatus; .
DR   GO; GO:0005887; C:integral component of plasma membrane; .
DR   GO; GO:0042470; C:melanosome; .
DR   GO; GO:0016020; C:membrane; .
DR   GO; GO:0005886; C:plasma membrane; .
DR   GO; GO:0015186; F:L-glutamine transmembrane transporter activity; .
DR   GO; GO:0015194; F:L-serine transmembrane transporter activity; .
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; .
DR   GO; GO:0005515; F:protein binding; .
DR   GO; GO:0004872; F:receptor activity; .
DR   GO; GO:0017153; F:sodium:dicarboxylate symporter activity; .
DR   GO; GO:0001618; F:virus receptor activity; .
DR   GO; GO:0006865; P:amino acid transport; .
DR   GO; GO:0006860; P:extracellular amino acid transport; .
DR   GO; GO:0006868; P:glutamine transport; .
DR   GO; GO:0006811; P:ion transport; .
DR   GO; GO:0015804; P:neutral amino acid transport; .
DR   GO; GO:0055085; P:transmembrane transport; .
DR   Gene3D; 1.10.3860.10; -; 1.
DR   InterPro; IPR001991; Na-dicarboxylate_symporter.
DR   InterPro; IPR018107; Na-dicarboxylate_symporter_CS.
DR   PANTHER; PTHR11958; PTHR11958; 1.
DR   Pfam; PF00375; SDF; 1.
DR   PRINTS; PR00173; EDTRNSPORT.
DR   SUPFAM; SSF118215; SSF118215; 1.
DR   PROSITE; PS00713; NA_DICARBOXYL_SYMP_1; 1.
DR   PROSITE; PS00714; NA_DICARBOXYL_SYMP_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Alternative splicing;
KW   Cell membrane; Complete proteome; Glycoprotein;
KW   Host cell receptor for virus entry; Membrane; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    541       Neutral amino acid transporter B(0).
FT                                /FTId=PRO_0000202082.
FT   TOPO_DOM      1     52       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     53     73       Helical. {ECO:0000255}.
FT   TRANSMEM     99    119       Helical. {ECO:0000255}.
FT   TRANSMEM    133    153       Helical. {ECO:0000255}.
FT   TOPO_DOM    154    224       Extracellular. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TRANSMEM    336    356       Helical. {ECO:0000255}.
FT   TRANSMEM    377    397       Helical. {ECO:0000255}.
FT   TRANSMEM    399    419       Helical. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine. {ECO:0000269|PubMed:
FT                                19413330, ECO:0000269|PubMed:22814378}.
FT   MOD_RES     493    493       Phosphoserine. {ECO:0000269|PubMed:
FT                                21406692}.
FT   MOD_RES     503    503       Phosphoserine. {ECO:0000269|PubMed:
FT                                19690332}.
FT   MOD_RES     535    535       Phosphoserine. {ECO:0000269|PubMed:
FT                                17081983, ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19349973}.
FT   VAR_SEQ       1    228       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046851.
FT   VAR_SEQ       1    203       MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGS
FT                                RDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALG
FT                                PERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGA
FT                                LGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINA
FT                                SVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRS
FT                                -> M (in isoform 2). {ECO:0000303|PubMed:
FT                                14702039}.
FT                                /FTId=VSP_046354.
FT   VARIANT      17     17       P -> A (in dbSNP:rs3027956).
FT                                /FTId=VAR_020439.
FT   VARIANT     512    512       V -> L (in dbSNP:rs3027961).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:19690332}.
FT                                /FTId=VAR_013517.
FT   CONFLICT     18     24       TANGGLA -> PPTGAWQ (). {ECO:0000305}.
FT   CONFLICT     44     44       Q -> L (). {ECO:0000305}.
FT   CONFLICT     84     87       ERLS -> GALE (). {ECO:0000305}.
FT   CONFLICT    341    341       V -> A (). {ECO:0000305}.
FT   CONFLICT    453    453       I -> V (). {ECO:0000305}.
FT   CONFLICT    460    460       D -> G (). {ECO:0000305}.
FT   CONFLICT    463    463       V -> A (). {ECO:0000305}.
FT   CONFLICT    508    508       D -> G (). {ECO:0000305}.
SQ   SEQUENCE   541 AA;  56598 MW;  AD61C789CCFFE934 CRC64;
     MVADPPRDSK GLAAAEPTAN GGLALASIED QGAAAGGYCG SRDQVRRCLR ANLLVLLTVV
     AVVAGVALGL GVSGAGGALA LGPERLSAFV FPGELLLRLL RMIILPLVVC SLIGGAASLD
     PGALGRLGAW ALLFFLVTTL LASALGVGLA LALQPGAASA AINASVGAAG SAENAPSKEV
     LDSFLDLARN IFPSNLVSAA FRSYSTTYEE RNITGTRVKV PVGQEVEGMN ILGLVVFAIV
     FGVALRKLGP EGELLIRFFN SFNEATMVLV SWIMWYAPVG IMFLVAGKIV EMEDVGLLFA
     RLGKYILCCL LGHAIHGLLV LPLIYFLFTR KNPYRFLWGI VTPLATAFGT SSSSATLPLM
     MKCVEENNGV AKHISRFILP IGATVNMDGA ALFQCVAAVF IAQLSQQSLD FVKIITILVT
     ATASSVGAAG IPAGGVLTLA IILEAVNLPV DHISLILAVD WLVDRSCTVL NVEGDALGAG
     LLQNYVDRTE SRSTEPELIQ VKSELPLDPL PVPTEEGNPL LKHYRGPAGD ATVASEKESV
     M
//
